For instance, insulin sensitizers (Thiazolidinediones and Biguanides), insulin secretagogues (Meglitinide and Sulfonylureas derivatives), dipeptidyl peptidase-4 (DPP-4) inhibitors, α-glucosidase inhibitors, and exogenous insulin have been extensively used to treat diabetes mellitus. Here, INS is linked to diabetes mellitus.